Your browser doesn't support javascript.
loading
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
Yang, Yang; Sheng, Jindong; Hu, Shuai; Cui, Yun; Xiao, Jing; Yu, Wei; Peng, Jing; Han, Wenke; He, Qun; Fan, Yu; Niu, Yuanjie; Lin, Jun; Tian, Ye; Chang, Chawnshang; Yeh, Shuyuan; Jin, Jie.
Afiliación
  • Yang Y; Department of Urology, Beijing Friendship Hospital, Capital Medical University, 100050, Beijing, China.
  • Sheng J; Department of Gynaecological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Hu S; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Cui Y; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
  • Xiao J; Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, 100020, Beijing, China.
  • Yu W; Department of Urology, Beijing Friendship Hospital, Capital Medical University, 100050, Beijing, China.
  • Peng J; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Han W; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
  • He Q; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Fan Y; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
  • Niu Y; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Lin J; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
  • Tian Y; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Chang C; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
  • Yeh S; Department of Urology, Peking University First Hospital, 100034, Beijing, China.
  • Jin J; Beijing Key Laboratory of Urogenital diseases (male) molecular diagnosis and treatment center, Beijing, China.
Cell Death Dis ; 13(6): 533, 2022 06 07.
Article en En | MEDLINE | ID: mdl-35672281
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Resección Transuretral de la Próstata Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Resección Transuretral de la Próstata Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido